Avenue Biosciences
PrivateLast Round
Seed
Jan 12, 2026
Total Funding Raised
$14.36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avenue Biosciences operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Seed round in January 2026.
Avenue Biosciences is a biotechnology company that provides a protein engineering platform powered by machine learning to optimize protein expression and production for biopharmaceutical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenue Biosciences Comparables
Compare Avenue Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MNDL Bio | 82% | |
| Cradle | 78% | |
| BigHat Biosciences | 77% |
For institutional investors. Book with your work email.
Avenue Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 12, 2026 | ||||
| Seed | Oct 22, 2024 | ||||
| Seed | Jan 16, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avenue Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tesi | Seed |
| University of Helsinki | Seed |
| Balnord | Seed |
| Inventure | Seed |
| Voima Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 73% MoM, from 653 to 1.1K.
- Jan 12, 2026
$5.7M raised in Seed round.
For institutional investors. Book with your work email.
Avenue Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avenue Biosciences's valuation, stock price, and market status.
Is Avenue Biosciences a public or private company?
Avenue Biosciences is a private company.
What is the current stock price of Avenue Biosciences?
Avenue Biosciences is a private company, so its shares have no public market price. Caplight tracks Avenue Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avenue Biosciences worth (valuation)?
Valuation information for Avenue Biosciences is not publicly available.
Can I buy Avenue Biosciences stock?
Avenue Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avenue Biosciences's last funding round?
Avenue Biosciences's most recent funding round was Seed on January 12, 2026.
Who are the main investors in Avenue Biosciences?
Key investors in Avenue Biosciences include Tesi, Balnord, Voima Ventures.
Will Avenue Biosciences IPO soon?
No public IPO plans have been announced for Avenue Biosciences.
How can I track Avenue Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Avenue Biosciences's shares on secondary markets.